Clinical trials
Phase 4 Major Depressive Disorder trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 3 |
| 2009 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2019 | 1 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Erlangen-Nürnberg Medical School | 2 |
| Boehringer Ingelheim | 1 |
| Eli Lilly and Company | 1 |
| Forest Laboratories | 1 |
| HolsboerMaschmeyer NeuroChemie GmbH | 1 |
| Janssen-Cilag Ltd. | 1 |
| Teva Branded Pharmaceutical Products R&D, Inc. | 1 |
| Zentrum für Integrative Psychiatrie | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Major Depressive Disorder | 9 |
| Depressive Disorder, Treatment-Resistant | 1 |
| Diabetic Neuropathies | 1 |
| Epilepsy, Rolandic | 1 |
| Migraine Disorders | 1 |
| Mood Disorders | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.